---
category: news
title: "Lantern Pharma Announces Positive Preclinical Data in Glioblastoma (GBM) with Drug Candidate LP-184 and Expands GBM Research Collaboration"
excerpt: "RADR Â® is Lantern's proprietary machine learning-based artificial intelligence platform that integrates data ... defined patients who could potentially benefit from LP-184-based therapy. \"This new data reinforces that LP-184 may have clinical utility ..."
publishedDateTime: 2021-08-19T12:52:00Z
originalUrl: "https://www.prnewswire.com/news-releases/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-and-expands-gbm-research-collaboration-301358943.html"
webUrl: "https://www.prnewswire.com/news-releases/lantern-pharma-announces-positive-preclinical-data-in-glioblastoma-gbm-with-drug-candidate-lp-184-and-expands-gbm-research-collaboration-301358943.html"
type: article
quality: 0
heat: 0
published: false

provider:
  name: PR Newswire
  domain: prnewswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mma.prnewswire.com/media/1216507/Lantern_Pharma_Logo.jpg?p=facebook"
    width: 939
    height: 491
    isCached: true

secured: "mPnSWcH4VdbqHhIIUxY5iwtxOSX1r/HDF1RhmNrY67uejGlxOcPWSMGHB1VvVS8FLzwaClGMWIRetZ7rshpdbztql49ocjjAURGBNRq+WZvT9z03vzo04rMWA0uXedftdR1QwKAw8ovoPdP9VWy2XY/0exm+iarfOXajU+NTyBQHwUSMhc4QFNwXjdVPn6m5GlN1xmq9WLLJujmHG2cUZU8FTXND99HiHQoH8BSIhnY+zz4aQUS80vJjVGt70/X1uHQvOD5heEwdAyVUlJvhkO2nDvlQjYaoHnC4/W8KDjDVTWMlfAlCns3ptJ71qylMp9czjVz378tMLRIz8KrCJLBcw50W1LE7dPg8qtVNKyQ=;3IG5iqW/J2qyPANuWZneVg=="
---

